Recent Updates in The Role of Immunotherapies in Early NSCLC: Translating Evidence to Clinical Practice - Episode 3
Overview and clinical implications of the CheckMate-816 study of neoadjuvant nivolumab plus platinum chemotherapy versus chemotherapy alone in early-stage NSCLC.